Pancreatic sphincterotomy to manage intraductal papillary mucinous neoplasm-related recurrent pancreatitis: are we ready for a controlled trial?

CC BY-NC-ND 4.0 · Endosc Int Open 2019; 07(12): E1583-E1584
DOI: 10.1055/a-1024-3924

Letter to the editor

Stefano Francesco Crinò

Digestive Endoscopy Unit, The Pancreas Institute, G.B. Rossi University Hospital, Verona, Italy

,

Maria Cristina Conti Bellocchi

Digestive Endoscopy Unit, The Pancreas Institute, G.B. Rossi University Hospital, Verona, Italy

,

Laura Bernardoni

Digestive Endoscopy Unit, The Pancreas Institute, G.B. Rossi University Hospital, Verona, Italy

,

Armando Gabbrielli

Digestive Endoscopy Unit, The Pancreas Institute, G.B. Rossi University Hospital, Verona, Italy

References
1 Gonzalez JM, Lorenzo D, Ratone JP. et al. Pancreatic sphincterotomy improves pain symptoms due to branch-duct intrapapillary mucinous neoplasia without worrisome features: a multicenter study. Endosc Int Open 2019; 7: E1130-E1134
2 Bernardoni L, Crinò SF, De Conti G. et al. Preliminary experience with pancreatic sphincterotomy as treatment for intraductal papillary mucinous neoplasm-associated recurrent pancreatitis. Endosc Int Open 2017; 5: E1144-E1150
3 Cotton PB, Durkalski V, Romagnuolo J. et al. Effect of endoscopic sphincterotomy for suspected sphincter of Oddi dysfunction on pain-related disability following cholecystectomy: the EPISOD randomized clinical trial. JAMA 2014; 311: 2101-2109
4 Kwok K, Chang J, Duan L. et al. Competing risks for mortality in patients with asymptomatic pancreatic cystic neoplasms: implications for clinical management. Am J Gastroenterol 2017; 112: 1330-1336
5 Oyama H, Tada M, Takagi K. et al. Long-term risk of malignancy in branch duct intraductal papillary mucinous neoplasms. Gastroenterology 2019; [Epub ahead of print]